A Universidade de Oxford (Reino Unido), em parceria com a farmacêutica britânica AstraZeneca, tem desenvolvido uma das vacinas candidatas ao combate à Covid-19. Atualmente a vacina resultou no desenvolvimento de respostas imunes em idosos, um dos principais grupos de risco da doença.
No Brasil, os testes estão sendo conduzidos no Rio de Janeiro, Instituto D’Or de Pesquisa e Ensino (IDOR) e da Rede D’Or, que cobriu os custos da primeira fase da pesquisa; e em São Paulo, pelo Centro de Referência para Imunobiológicos Especiais (Crie) da Unifesp.
26.10.2020
Cookie | Duração | Descrição |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |